S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.14
-6.8%
$0.18
$0.13
$47.10
$4.42M0.674.89 million shs1.17 million shs
Biomerica, Inc. stock logo
BMRA
Biomerica
$0.77
-7.2%
$0.99
$0.70
$2.13
$12.95M-1.0484,991 shs132,974 shs
Remedent, Inc. stock logo
REMI
Remedent
$0.06
$0.06
$0.00
$0.17
$1.10M-0.2440,380 shsN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$290.00
$294.94
$198.00
$364.00
N/A0.936 shsN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$30.89
-1.3%
$33.03
$26.27
$43.24
$6.49B0.984.85 million shs2.82 million shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-4.09%-7.42%-2.09%-86.80%-99.44%
Biomerica, Inc. stock logo
BMRA
Biomerica
-7.00%-5.04%-27.36%-19.79%-54.14%
Remedent, Inc. stock logo
REMI
Remedent
0.00%-15.84%+30.95%-45.00%-67.65%
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
0.00%0.00%-3.50%+3.94%-19.44%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-1.31%-4.19%-5.94%-14.08%-24.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.4132 of 5 stars
2.02.00.00.03.30.00.0
Biomerica, Inc. stock logo
BMRA
Biomerica
N/AN/AN/AN/AN/AN/AN/AN/A
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/AN/AN/AN/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
4.6948 of 5 stars
3.32.03.33.82.91.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/A$77.0056,517.65% Upside
Biomerica, Inc. stock logo
BMRA
Biomerica
N/AN/AN/AN/A
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
2.00
HoldN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.67
Moderate Buy$39.5027.87% Upside

Current Analyst Ratings

Latest BMRA, BIOL, REMI, SARTF, and XRAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/1/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$41.00
2/29/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$42.00
2/26/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$42.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$49.16M0.09N/AN/A($0.07) per share-1.94
Biomerica, Inc. stock logo
BMRA
Biomerica
$5.34M2.43N/AN/A$0.70 per share1.10
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$3.67BN/A$29.00 per share10.00$81.84 per shareN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.97B1.62$4.77 per share6.48$15.55 per share1.99

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$32.58N/AN/A-41.97%-555.22%-53.10%5/9/2024 (Estimated)
Biomerica, Inc. stock logo
BMRA
Biomerica
-$7.14M-$0.37N/AN/A-117.46%-59.76%-48.22%8/23/2024 (Estimated)
Remedent, Inc. stock logo
REMI
Remedent
N/AN/A0.00N/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$221.98M$3.2489.5136.94N/A6.04%12.44%3.97%N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$132M-$0.62N/A12.921.27-3.33%11.14%5.22%5/2/2024 (Confirmed)

Latest BMRA, BIOL, REMI, SARTF, and XRAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.42N/A-$0.42N/AN/AN/A  
4/12/2024Q3 2024
Biomerica, Inc. stock logo
BMRA
Biomerica
N/A-$0.11-$0.11-$0.11N/A$1.02 million
3/21/2024Q4 2023
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A-$1.76-$1.76-$1.76N/A$13.49 million
2/29/2024Q4 23
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.43$0.44+$0.01$0.56$972.61 million$1.01 billion    
2/16/2024Q4 2023
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$1.31$1.01-$0.30$1.89$900.00 million$915.06 million
1/16/2024Q2 2024
Biomerica, Inc. stock logo
BMRA
Biomerica
N/A-$0.09-$0.09-$0.09N/A$1.57 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Biomerica, Inc. stock logo
BMRA
Biomerica
N/AN/AN/AN/AN/A
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.642.07%+11.87%N/A 13 Years

Latest BMRA, BIOL, REMI, SARTF, and XRAY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
quarterly$0.161.92%3/27/20243/29/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
34.06
1.26
0.68
Biomerica, Inc. stock logo
BMRA
Biomerica
N/A
5.63
4.62
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
1.82
1.47
0.69
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.55
1.38
0.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Biomerica, Inc. stock logo
BMRA
Biomerica
22.28%
Remedent, Inc. stock logo
REMI
Remedent
N/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.01%
Biomerica, Inc. stock logo
BMRA
Biomerica
13.50%
Remedent, Inc. stock logo
REMI
Remedent
N/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.76%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
15732.52 million32.52 millionNot Optionable
Biomerica, Inc. stock logo
BMRA
Biomerica
6216.82 million14.55 millionOptionable
Remedent, Inc. stock logo
REMI
Remedent
320.00 millionN/ANot Optionable
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
14,614N/AN/ANot Optionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
15,000207.36 million205.79 millionOptionable

BMRA, BIOL, REMI, SARTF, and XRAY Headlines

SourceHeadline
Asset Management One Co. Ltd. Has $73,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Asset Management One Co. Ltd. Has $73,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 15 at 4:43 AM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLCDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLC
marketbeat.com - April 12 at 9:38 PM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of "Moderate Buy" by AnalystsDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of "Moderate Buy" by Analysts
americanbankingnews.com - April 10 at 2:30 AM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Moderate Buy" from BrokeragesDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - April 10 at 2:29 AM
Dentsply Sirona to Host First Quarter Conference Call on May 2ndDentsply Sirona to Host First Quarter Conference Call on May 2nd
globenewswire.com - April 9 at 4:30 PM
Cambiar Investors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Cambiar Investors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 7 at 8:24 PM
Heres Why Dentsply International (XRAY) is a Strong Value StockHere's Why Dentsply International (XRAY) is a Strong Value Stock
zacks.com - April 4 at 10:45 AM
Former Dentsply Sirona CEO joins healthcare-focused PE firmFormer Dentsply Sirona CEO joins healthcare-focused PE firm
beckersdental.com - April 2 at 8:58 PM
Cone Beam Imaging Systems Market Future Growth with Technology and Current Trends 2024 to 2032Cone Beam Imaging Systems Market Future Growth with Technology and Current Trends 2024 to 2032
taiwannews.com.tw - April 2 at 3:20 PM
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio NowReasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
zacks.com - April 2 at 10:46 AM
3M Spinoff Solventum Stock Is Down. 3M Stock Is Not. What Happens Next.3M Spinoff Solventum Stock Is Down. 3M Stock Is Not. What Happens Next.
msn.com - April 1 at 3:38 PM
Raymond James & Associates Acquires 234,322 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Raymond James & Associates Acquires 234,322 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - March 30 at 4:33 AM
Global Dental Simulator Industry is expected to grow at a rapid rate of 7.8% CAGR and reach US$ 780.5 Million by 2033 | FMIGlobal Dental Simulator Industry is expected to grow at a rapid rate of 7.8% CAGR and reach US$ 780.5 Million by 2033 | FMI
fmiblog.com - March 28 at 4:22 PM
S&P 500 to add 3M and GE spin-offs, replacing VF and Dentsply SironaS&P 500 to add 3M and GE spin-offs, replacing VF and Dentsply Sirona
finance.yahoo.com - March 27 at 6:56 PM
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
prnewswire.com - March 27 at 6:12 PM
Bar Harbor Wealth Management Buys Shares of 138,564 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Bar Harbor Wealth Management Buys Shares of 138,564 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - March 27 at 9:22 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Has Announced That It Will Be Increasing Its Dividend To $0.16DENTSPLY SIRONA (NASDAQ:XRAY) Has Announced That It Will Be Increasing Its Dividend To $0.16
finance.yahoo.com - March 23 at 4:48 PM
Q1 2024 EPS Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Lowered by AnalystQ1 2024 EPS Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Lowered by Analyst
marketbeat.com - March 22 at 7:34 AM
Heres Why Dentsply International (XRAY) is a Strong Momentum StockHere's Why Dentsply International (XRAY) is a Strong Momentum Stock
zacks.com - March 21 at 11:46 AM
Heres Why Dentsply International (XRAY) is a Strong Momentum StockHere's Why Dentsply International (XRAY) is a Strong Momentum Stock
zacks.com - March 21 at 11:11 AM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by DNB Asset Management ASDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by DNB Asset Management AS
marketbeat.com - March 21 at 4:54 AM
Why Dentsply International (XRAY) is a Top Value Stock for the Long-TermWhy Dentsply International (XRAY) is a Top Value Stock for the Long-Term
zacks.com - March 19 at 10:41 AM
Deutsche Bank AG Has $26.36 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Deutsche Bank AG Has $26.36 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - March 18 at 4:44 AM
XRAY Oct 2024 40.000 callXRAY Oct 2024 40.000 call
ca.finance.yahoo.com - March 16 at 8:45 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

BIOLASE logo

BIOLASE

NASDAQ:BIOL
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Biomerica logo

Biomerica

NASDAQ:BMRA
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Remedent logo

Remedent

OTCMKTS:REMI
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft

OTCMKTS:SARTF
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
DENTSPLY SIRONA logo

DENTSPLY SIRONA

NASDAQ:XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina